BMS-650032

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BMS-650032, covering 2010-09-13 to 2016-05-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials [Phase 2]

See pricing